Here are five things to know:
1. Allegedly, Paradigm Spine marketed its coflex-F device for surgical uses not approved by the FDA, between 2011 and 2013.
2. Consequently, healthcare providers submitted false claims to Medicare and other federal programs for using the device in spine surgeries that weren’t approved.
3. The allegations also include Paradigm Spine offering false recommendations on how to code claims for procedures using the device, from 2012 to 2015.
4. Thus, healthcare providers submitted false claims to federal programs for spine surgeries that were not eligible for reimbursement.
5. Paradigm Spine denies all allegations.
More articles on devices:
Aurora Spine completes non-brokered private placement of 2.53M common shares: 4 key notes
Camber Capital Management’s stake in NuVasive totals $79.7M: 3 points
Tyber Medical expands to Australia: 3 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
